Payment overview · 2025
General Payments
$243.31
3 reported records · 3 companies
Healthcare provider profile · identity verified
Samir Azzam, M.D
Allopathic & Osteopathic Physicians|Family Medicine · ANAHEIM, CA · NPI 1891744538
Verified facts
What the public records show
CMS Open Payments records show Samir Azzam, M.D received $243.31 in general payments during 2025 across 3 reported records.
ANI Pharmaceuticals, Inc. accounted for 51.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
SANOFI-AVENTIS U.S. LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LANTUS as an associated drug or biological on 12 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Lantus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $124.99 | 51.4% | 1 | 2025 |
| SANOFI-AVENTIS U.S. LLC | Unresolved — no canonical attribution shown | $99.99 | 41.1% | 1 | 2025 |
| Echosens North America, Inc. | Unresolved — no canonical attribution shown | $18.33 | 7.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $143.32 | 2 |
| Education | $99.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PURIFIED CORTROPHIN GEL Normalized: purified cortrophin gel |
Drug | ANI Pharmaceuticals, Inc. | $124.99 | 1 | 2025 |
Source payment records
|
|||||
| KEVZARA Normalized: kevzara |
Biological | SANOFI-AVENTIS U.S. LLC | $99.99 | 1 | 2025 |
Source payment records
|
|||||
| Fibroscan Normalized: fibroscan |
Device | Echosens North America, Inc. | $18.33 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC Exact reporting entity; no affiliate inference |
2025 | LANTUS open payments reported associated product |
CMS Open Payments — General Payments 12 supporting records · 11 recipient NPIs · example record 1233196856 |
Lantus · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 917 | 250 |
| Gabapentin | Gabapentin | 464 | 113 |
| Losartan Potassium | Losartan Potassium | 452 | 133 |
| Metformin Hcl | Metformin Hcl | 450 | 136 |
| Amlodipine Besylate | Amlodipine Besylate | 439 | 118 |
| Levothyroxine Sodium | Levothyroxine Sodium | 397 | 91 |
| Eliquis | Apixaban | 345 | 54 |
| Omeprazole | Omeprazole | 341 | 95 |
| Metoprolol Tartrate | Metoprolol Tartrate | 314 | 77 |
| Pantoprazole Sodium | Pantoprazole Sodium | 291 | 87 |
| Lisinopril | Lisinopril | 285 | 79 |
| Furosemide | Furosemide | 284 | 71 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 276 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 237 | 70 |
| Glipizide | Glipizide | 234 | 54 |
| Famotidine | Famotidine | 229 | 82 |
| Ibuprofen | Ibuprofen | 202 | 60 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 171 | 49 |
| Donepezil Hcl | Donepezil Hcl | 170 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 158 | 51 |
| Metoprolol Succinate | Metoprolol Succinate | 156 | 40 |
| Diclofenac Sodium | Diclofenac Sodium | 155 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 153 | 42 |
| Trazodone Hcl | Trazodone Hcl | 153 | 53 |
| Potassium Chloride | Potassium Chloride | 145 | 43 |
| Baclofen | Baclofen | 142 | 43 |
| Ozempic | Semaglutide | 137 | 23 |
| Alendronate Sodium | Alendronate Sodium | 135 | 29 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 135 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 133 | 30 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 131 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 129 | 44 |
| Jardiance | Empagliflozin | 129 | 23 |
| Carvedilol | Carvedilol | 126 | 27 |
| Januvia | Sitagliptin Phosphate | 116 | 25 |
| Ondansetron Hcl | Ondansetron Hcl | 114 | 39 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 114 | 58 |
| Memantine Hcl | Memantine Hcl | 108 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 106 | 26 |
| Mirtazapine | Mirtazapine | 103 | 26 |
| Simvastatin | Simvastatin | 92 | 28 |
| Azithromycin | Azithromycin | 91 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 89 | 27 |
| Sertraline Hcl | Sertraline Hcl | 89 | 24 |
| Sodium Chloride | 0.9 % Sodium Chloride | 88 | 27 |
| Amoxicillin | Amoxicillin | 84 | 44 |
| Mupirocin | Mupirocin | 84 | 27 |
| Meloxicam | Meloxicam | 83 | 30 |
| Metformin Hcl Er | Metformin Hcl | 82 | 20 |
| Allopurinol | Allopurinol | 81 | 23 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 80 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 80 | 21 |
| Lactulose | Lactulose | 80 | 29 |
| Clonidine Hcl | Clonidine Hcl | 77 | 43 |
| Levetiracetam | Levetiracetam | 75 | 15 |
| Montelukast Sodium | Montelukast Sodium | 75 | 20 |
| Prednisone | Prednisone | 73 | 39 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 73 | 52 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 72 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 72 | 19 |
| Atenolol | Atenolol | 71 | 24 |
| Oxybutynin Chloride | Oxybutynin Chloride | 70 | 15 |
| Buspirone Hcl | Buspirone Hcl | 69 | 18 |
| Enoxaparin Sodium | Enoxaparin Sodium | 69 | suppressed |
| Ketoconazole | Ketoconazole | 68 | 18 |
| Novolin R Flexpen | Insulin Regular, Human | 67 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 66 | 18 |
| Methocarbamol | Methocarbamol | 64 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 63 | 29 |
| Digoxin | Digoxin | 63 | suppressed |
| Xarelto | Rivaroxaban | 63 | suppressed |
| Finasteride | Finasteride | 62 | 21 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 62 | 18 |
| Midodrine Hcl | Midodrine Hcl | 62 | 19 |
| Amiodarone Hcl | Amiodarone Hcl | 59 | 13 |
| Farxiga | Dapagliflozin Propanediol | 59 | 12 |
| Entresto | Sacubitril/Valsartan | 58 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 58 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 57 | 24 |
| Lovastatin | Lovastatin | 57 | 16 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 56 | suppressed |
| Humulin R | Insulin Regular, Human | 55 | 19 |
| Naproxen | Naproxen | 53 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 53 | 18 |
| Erythromycin Ethylsuccinate | Erythromycin Ethylsuccinate | 52 | suppressed |
| Hydrocortisone | Hydrocortisone | 52 | 20 |
| Risperidone | Risperidone | 52 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 51 | 11 |
| Latanoprost | Latanoprost | 51 | 17 |
| Lorazepam | Lorazepam | 51 | suppressed |
| Glimepiride | Glimepiride | 49 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 48 | 39 |
| Linzess | Linaclotide | 47 | 15 |
| Diltiazem Hcl | Diltiazem Hcl | 45 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | 13 |
| Scopolamine | Scopolamine | 45 | suppressed |
| Trulicity | Dulaglutide | 45 | 12 |
| Celecoxib | Celecoxib | 43 | 13 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 43 | 20 |
| Meclizine Hcl | Meclizine Hcl | 41 | 20 |
| Ezetimibe | Ezetimibe | 40 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 13 |
| Benazepril Hcl | Benazepril Hcl | 38 | 11 |
| Sucralfate | Sucralfate | 38 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 37 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 37 | 13 |
| Megestrol Acetate | Megestrol Acetate | 37 | suppressed |
| Budesonide | Budesonide | 35 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 35 | 16 |
| Valproic Acid | Valproic Acid | 35 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 34 | 12 |
| Clobetasol Propionate | Clobetasol Propionate | 33 | 15 |
| Novolog Flexpen | Insulin Aspart | 33 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 32 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 32 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 32 | 11 |
| Tradjenta | Linagliptin | 32 | suppressed |
| Brilinta | Ticagrelor | 31 | suppressed |
| Cilostazol | Cilostazol | 31 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 31 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 30 | suppressed |
| Alprazolam | Alprazolam | 30 | suppressed |
| Gemfibrozil | Gemfibrozil | 30 | suppressed |
| Bumetanide | Bumetanide | 29 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 29 | 11 |
| Lidocaine | Lidocaine | 29 | 11 |
| Terbinafine Hcl | Terbinafine Hcl | 29 | suppressed |
| Lamotrigine | Lamotrigine | 28 | suppressed |
| Lansoprazole | Lansoprazole | 28 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 26 | 13 |
| Metoclopramide Hcl | Metoclopramide Hcl | 26 | suppressed |
| Primidone | Primidone | 26 | suppressed |
| Spironolactone | Spironolactone | 26 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 19 |
| Buprenorphine Hcl | Buprenorphine Hcl | 24 | suppressed |
| Felodipine Er | Felodipine | 24 | suppressed |
| Monoject Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 24 | suppressed |
| Olanzapine | Olanzapine | 24 | suppressed |
| Acyclovir | Acyclovir | 23 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Dutasteride | Dutasteride | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Enulose | Lactulose | 22 | suppressed |
| Rexulti | Brexpiprazole | 22 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 18 |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 20 | 13 |
| Glipizide Er | Glipizide | 20 | suppressed |
| Invokana | Canagliflozin | 20 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 20 | suppressed |
| Sulindac | Sulindac | 20 | suppressed |
| Amantadine | Amantadine Hcl | 19 | suppressed |
| Cephalexin | Cephalexin | 19 | 17 |
| Diclofenac Potassium | Diclofenac Potassium | 19 | suppressed |
| Fluocinonide | Fluocinonide | 19 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 19 | suppressed |
| Nystatin | Nystatin | 19 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Humalog | Insulin Lispro | 18 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 16 |
| Ondansetron Odt | Ondansetron | 18 | 15 |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Vascepa | Icosapent Ethyl | 18 | suppressed |
| Calcitriol | Calcitriol | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Topiramate | Topiramate | 17 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Ingrezza | Valbenazine Tosylate | 16 | suppressed |
| Levemir | Insulin Detemir | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Glucagon Emergency Kit | Glucagon Hcl | 15 | 11 |
| Hydroxyurea | Hydroxyurea | 15 | suppressed |
| Premarin | Estrogens, Conjugated | 15 | suppressed |
| Sotalol | Sotalol Hcl | 15 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Alogliptin | Alogliptin Benzoate | 14 | suppressed |
| Erythromycin | Erythromycin Base | 14 | 11 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | 11 |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 12 |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 12 | suppressed |
| Enbrel | Etanercept | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 12 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Promethazine-Dm | Promethazine/Dextromethorphan | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $243.31 · 3 records | ANI Pharmaceuticals, Inc. | Fibroscan, KEVZARA, PURIFIED CORTROPHIN GEL | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with SANOFI-AVENTIS U.S. LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error